BioVie Announces Update To Parkinson’s Phase 3 Development Program
BIVI•BioVie updates Parkinson’s Phase 3 program
Sept. 8 (Reuters) - BioVie Inc. BIVI.O:
- BioVie announces update to Parkinson’s Phase 3 development program
- BioVie requests end-of-Phase 2 meeting with FDA, expects feedback before year-end




